Open access · CC-BY
via OpenAlex
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Samuel W. Brady, Yanling Liu, Xiaotu Ma, Alexander M. Gout, Kohei Hagiwara, Xin Zhou, Jian Wang, Michael Macias, Xiaolong Chen, John Easton, Heather L. Mulder, Michael Rusch, Lu Wang, Joy Nakitandwe, Shaohua Lei
Nature Communications · 2020 · ▲ 175 citations
Abstract
Neuroblastoma is a pediatric malignancy with heterogeneous clinical outcomes. To better understand neuroblastoma pathogenesis, here we analyze whole-genome, whole-exome and/or transcriptome data from 702 neuroblastoma samples. Forty percent of samples harbor at least one recurrent driver gene alteration and most aberrations, including MYCN, ATRX, and TERT alterations, differ in frequency by age. MYCN alterations occur at median 2.3 years of age, TERT at 3.8 years, and ATRX at 5.6 years. COSMIC mutational signature 18, previously associated with reactive oxygen species, is the most common cause of driver point mutations in neuroblastoma, including most ALK and Ras-activating variants. Signature 18 appears early and is continuous throughout disease evolution. Signature 18 is enriched in neuroblastomas with MYCN amplification, 17q gain, and increased expression of mitochondrial ribosome and electron transport-associated genes. Recurrent FGFR1 variants in six patients, and ALK N-terminal structural alterations in five samples, identify additional patients potentially amenable to precision therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41467-020-18987-4
- Canonical
- link ↗
- Fetched
- 2026-07-25 MST
Cite this
APA
Brady, S.W., Liu, Y., Ma, X., Gout, A.M., Hagiwara, K., Zhou, X., Wang, J., Macias, M., Chen, X., Easton, J., Mulder, H.L., Rusch, M., Wang, L., Nakitandwe, J., Lei, S., Davis, E.M., Naranjo, A., Cheng, C., Maris, J.M., & Downing, J.R. (2020). Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations. <em>Nature Communications</em>. https://doi.org/10.1038/s41467-020-18987-4
Vancouver
Brady SW, Liu Y, Ma X, Gout AM, Hagiwara K, Zhou X, et al. Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations. Nature Communications. 2020. doi:10.1038/s41467-020-18987-4.
BibTeX
@article{samuel2020Panneu,
title = {Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations},
author = {Samuel W. Brady and Yanling Liu and Xiaotu Ma and Alexander M. Gout and Kohei Hagiwara and Xin Zhou and Jian Wang and Michael Macias and Xiaolong Chen and John Easton and Heather L. Mulder and Michael Rusch and Lu Wang and Joy Nakitandwe and Shaohua Lei and Eric M. Davis and Arlene Naranjo and Cheng Cheng and John M. Maris and James R. Downing and Nai‐Kong V. Cheung and Michael D. Hogarty and Michael A. Dyer and Jinghui Zhang},
journal = {Nature Communications},
year = {2020},
doi = {10.1038/s41467-020-18987-4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University Hospital, Basel, Switzerland 2006
Open access · US-GOV
Quantification of Oxidative Stress in Patients With Age-Related Macular Degeneration Prior to and After Photodynamic Therapy: a Comet Assay Analysis
Neurobiology of Aging 2016
Preprint · OA
Age increases reactive oxygen species production in macrophages and potentiates oxidative damage after spinal cord injury
Science 1997
Citation only
Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular Degeneration
St. Erik Eye Hospital 2006
Open access · US-GOV
A Prospective, Randomized, Double-masked, Controlled Study on Intravitreal Bevacizumab (Avastin) Versus Verteporfin (Visudyne) Photodynamic Therapy (PDT) for Patients With Neovascular Age-related Macular Degeneration (AMD)
Genome Medicine 2021
Open access · CC-BY
An epigenetic and transcriptomic signature of immune tolerance in human monocytes through multi-omics integration
Free Radical Biology and Medicine 2014
Citation only